Researchers claim to have found a combination of existing drugs which can be effective against blood cancer that affects mainly older adults. Researchers tested to see if existing drug arsenic trioxide (ATO) was effective in combination with all-trans retinoic acid (ATRA) in both the mouse model and in humans. They determined that the combination proved `powerfully and exquisitely effective` against acute myeloid leukaemia (AML)While most patients initially respond to chemotherapy against (AML) more than half of those who respond will eventually relapse as the cancer cells develop resistance to treatment. There is an acute need to develop rational combinations to